You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 34 No. 1, January 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Monoamine Metabolism in Human Brain

Donald S. Robinson, MD; Theodore L. Sourkes, PhD; Alexander Nies, MD; Lawrence S. Harris, MD; Sydney Spector, PhD; Diantha L. Bartlett, MS; Irwin S. Kaye, MD

Arch Gen Psychiatry. 1977;34(1):89-92.


Abstract

• Norepinephrine (NE), dopamine (DA), tyrosine hydroxylase (TH), catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO) levels were measured in human brain tissue obtained at autopsy from a series of 39 patients dying of various medical and accidental causes. The nine following brain areas were studied: globus pallidus, thalamus, hypothalamus, hippocampus, substantia nigra, floor of the fourth ventricle, orbital cortex, caudate nucleus, and mammillary bodies. Enzyme activity correlated positively with age in all brain areas for MAO (with both benzylamine and tryptamine substrates) but no consistent pattern of correlation was found for COMT and TH. Mean MAO activity was significantly higher in women than men. There is increased brain MAO activity during late childhood and adolescence. These data are consistent with previous evidence suggesting that age and sex are important determinants of amine metabolism in the human central nervous system.



Author Affiliations

From the Departments of Medicine, Psychiatry, Pathology, and Epidemiology and Community Medicine, University of Vermont College of Medicine, Burlington, Vt (Drs Robinson, Nies, Harris, Kaye, and Ms Bartlett); Department of Psychiatry, McGill University, Montreal (Dr Sourkes); and the Department of Pharmacology, Roche Institute of Molecular Biology, Nutley, NJ (Dr Spector). Dr Nies is now with the Department of Psychiatry, Dartmouth Medical School, Hanover, NH.


Footnotes

Accepted for publication Sept 13, 1976.

Reprint requests to Given Medical Bldg, University of Vermont College of Medicine, Burlington, VT 05401 (Dr Robinson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Monoamine Oxidase and Criminality: Identifying an Apparent Biological Marker for Antisocial Behavior
ELLIS
Journal of Research in Crime and Delinquency 1991;28:227-251.
ABSTRACT  

Pretreatment DST and Hypothalamic-Pituitary-Adrenocortical Function in Depressed Patients and Comparison Groups: A Multicenter Study
Stokes et al.
Arch Gen Psychiatry 1984;41:257-267.
ABSTRACT  

Brain Monoamine Oxidase Activity in Schizophrenics and Controls
Reveley et al.
Arch Gen Psychiatry 1981;38:663-665.
ABSTRACT  

Mental symptoms in Huntington's disease and a possible primary aminergic neuron lesion
Mann et al.
Science 1980;210:1369-1371.
ABSTRACT  

The Dose-Response Ratio in Electroconvulsive Therapy: A Preliminary Study
Price et al.
Arch Gen Psychiatry 1978;35:1131-1136.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.